BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MedPharm Ltd Appoints Geoffrey Vernon As Chairman


4/10/2006 2:25:25 PM

CHICAGO--(BUSINESS WIRE)--April 9, 2006--UK-based topical pharmaceutical development specialist MedPharm Ltd today announced at BIO 2006 in Chicago that it has appointed Dr Geoffrey Vernon as Chairman. Dr Vernon is well respected in both the pharmaceutical industry and investor community with a distinguished international career, including senior roles at Schering and Ciba-Geigy, and in venture capital as a partner at Advent Ltd and an executive director at Rothschild Asset Management. Since 1998, he's been chairman of Ziggus Holdings which specialises in advising fast growing life science and biopharmaceutical companies. Founded in 1999, MedPharm itself has experienced a rapid period of growth, fuelled by strong revenue growth in contract formulation services. This has enabled the company to create its own portfolio of drug delivery systems and an internal drug development programme. Dr Vernon will be working with the Board and management to develop and implement the future growth strategies of the Company, which include raising funds to exploit these opportunities and to facilitate MedPharm's development as a specialist pharmaceutical company.

Read at press release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES